Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4751254
Max Phase: Preclinical
Molecular Formula: C27H32FN7O3
Molecular Weight: 521.60
Molecule Type: Unknown
Associated Items:
ID: ALA4751254
Max Phase: Preclinical
Molecular Formula: C27H32FN7O3
Molecular Weight: 521.60
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1CCNC(=O)COc2ccc(F)cc2C(=O)N2CCCC[C@H]2c2cc3nc([C@H]4C[C@H](N)C4)cc1n3n2
Standard InChI: InChI=1S/C27H32FN7O3/c1-33-9-7-30-25(36)15-38-23-6-5-17(28)12-19(23)27(37)34-8-3-2-4-22(34)21-13-24-31-20(16-10-18(29)11-16)14-26(33)35(24)32-21/h5-6,12-14,16,18,22H,2-4,7-11,15,29H2,1H3,(H,30,36)/t16-,18-,22-/m0/s1
Standard InChI Key: XTQFQCDOONDMIK-ZJBJCVSYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 521.60 | Molecular Weight (Monoisotopic): 521.2551 | AlogP: 2.39 | #Rotatable Bonds: 1 |
Polar Surface Area: 118.09 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.31 | CX Basic pKa: 10.06 | CX LogP: 1.59 | CX LogD: -0.92 |
Aromatic Rings: 3 | Heavy Atoms: 38 | QED Weighted: 0.50 | Np Likeness Score: -0.77 |
1. Yamaguchi-Sasaki T,Kawaguchi T,Okada A,Tokura S,Tanaka-Yamamoto N,Takeuchi T,Ogata Y,Takahashi R,Kurimoto-Tsuruta R,Tamaoki T,Sugaya Y,Abe-Kumasaka T,Arikawa K,Yoshida I,Sugiyama H,Kanuma K,Yoshinaga M. (2020) Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties., 28 (24): [PMID:33190073] [10.1016/j.bmc.2020.115818] |
Source(1):